Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IGHA1 antibody

This Rabbit Polyclonal antibody specifically detects IGHA1 in IHC and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7246370

Quick Overview for IGHA1 antibody (ABIN7246370)

Target

IGHA1 (Immunoglobulin Heavy Constant alpha 1 (IGHA1))

Reactivity

  • 17
  • 2
  • 2
Human

Host

  • 14
  • 3
Rabbit

Clonality

  • 13
  • 4
Polyclonal

Conjugate

  • 10
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IGHA1 antibody is un-conjugated

Application

  • 9
  • 7
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA
  • Characteristics

    Polyclonal Antibody

    Purification

    Antigen affinity purification

    Immunogen

    Fusion protein of human IGHA1

    Isotype

    IgG
  • Application Notes

    IHC 1:50-1:300, ELISA 1:5000-1:10000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.14 mg/mL

    Buffer

    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C. Avoid freeze / thaw cycles.
  • Target

    IGHA1 (Immunoglobulin Heavy Constant alpha 1 (IGHA1))

    Alternative Name

    IGHA1

    Background

    Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268). Ig alpha is the major immunoglobulin class in body secretions (PubMed:2241915).

    UniProt

    P01876
You are here:
Chat with us!